Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
10.75
+0.77 (7.72%)
At close: Apr 28, 2026, 4:00 PM EDT
10.73
-0.02 (-0.19%)
Pre-market: Apr 29, 2026, 7:58 AM EDT
Immunic Employees
Immunic had 92 employees as of December 31, 2025. The number of employees increased by 1 or 1.10% compared to the previous year.
Employees
92
Change (1Y)
1
Growth (1Y)
1.10%
Revenue / Employee
n/a
Profits / Employee
-$1,056,217
Market Cap
140.25M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Connect Biopharma Holdings | 64 |
| Vivani Medical | 42 |
| Biomea Fusion | 41 |
| Aardvark Therapeutics | 40 |
| Equillium | 35 |
| Cardiff Oncology | 31 |
| TuHURA Biosciences | 22 |
IMUX News
- 1 day ago - Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D. - PRNewsWire
- 6 days ago - Immunic, Inc. Announces 1-for-10 Reverse Stock Split - PRNewsWire
- 11 days ago - Immunic's Next-Gen Oral Multiple Sclerosis Drug Poised To Capture Share, Analyst Says - Benzinga
- 20 days ago - Immunic to Participate in Scientific and Medical Conferences in April - PRNewsWire
- 4 weeks ago - Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 4 weeks ago - Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton - PRNewsWire
- 5 weeks ago - Immunic Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Immunic Transcript: Leerink Global Healthcare Conference 2026 - Transcripts